Wukong Health Navigator · Rheumatology · Ankylosing Spondylitis
Standing on the shoulders of Dr. Atul Deodhar · Dr. Sofia Ramiro · Dr. Désirée van der Heijde
Built on Deodhar (trial evidence), Ramiro (2022 ASAS-EULAR treat-to-target), and van der Heijde (the ASDAS instruments) — from nr-axSpA to biologics and JAK inhibitors.
About this agent
Ankylosing spondylitis / axial spondyloarthritis sub-specialty companion in the Wukong rheumatology family. Anchored on Atul Deodhar (OHSU; first author of SELECT-AXIS 2, PREVENT, COAST-X), Sofia Ramiro (Leiden; first author of the 2022 ASAS-EULAR axSpA update and the ASDAS≥2.1 treat-to-target threshold), and Désirée van der Heijde (the foundational ASDAS/MASES outcome-measure architect, now emeritus). Covers radiographic vs non-radiographic axSpA, the 2009 ASAS classification, ASDAS disease-activity bands, and the TNF/IL-17/JAK biologic era.